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Abstract
Urban living in modern large cities has significant adverse effects on
health, increasing the risk of several chronic diseases. We focus on the two
leading clusters of chronic disease, heart disease and diabetes, and develop
data-driven methods to predict hospitalizations due to these conditions.
We base these predictions on the patients’ medical history, recent and
more distant, as described in their Electronic Health Records (EHR). We
formulate the prediction problem as a binary classification problem and
consider a variety of machine learning methods, including kernelized and
sparse Support Vector Machines (SVM), sparse logistic regression, and
random forests. To strike a balance between accuracy and interpretabil-
ity of the prediction, which is important in a medical setting, we propose
two novel methods: K-LRT, a likelihood ratio test-based method, and a
Joint Clustering and Classification (JCC) method which identifies hidden
patient clusters and adapts classifiers to each cluster. We develop theo-
retical out-of-sample guarantees for the latter method. We validate our
algorithms on large datasets from the Boston Medical Center, the largest
safety-net hospital system in New England.
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1 Introduction
Living in modern large cities is impacting our health in many different ways [1].
Primarily due to: (i) stress associated with fast-paced urban life, (ii) a sedentary
lifestyle due to work conditions and lack of time, (iii) air pollution, and (iv) a
disproportionate number of people living in poverty, urban populations face an
increased risk for the development of chronic health conditions [2]. For example,
according to the World Health Organization [3], ambient (outdoor air) pollution
was estimated in 2012 to cause 3 million premature deaths worldwide per year;
this mortality is due to exposure to small particulate matter of 10 microns or
less in diameter (PM10), which cause cardiovascular, respiratory disease, and
cancers. In fact, the vast majority (about 72%) of these air pollution-related
premature deaths were due to ischemic heart disease and strokes.
There is an increasing percentage of the world population facing the adverse
health effects of urban living. Specifically, according to the United Nations [4],
54% of the earth’s population resides in urban areas, a percentage which is
expected to reach 66% by 2050. It becomes evident that the health of citizens
should become an important priority in the emerging smart city agenda [5]. To
that end, smart health care –“smart health” as it has been called– involves the
use of ehealth and mhealth systems, intelligent and connected medical devices,
and the implementation of policies that encourage health, wellness, and well-
being [6]. It is estimated that by 2020 the smart city market will be worth
about $1.5 trillion, with smart health corresponding to 15% of that amount [6].
Additional potential actions smart cities can adopt include ways to improve city
life, reduce congestion and air pollution levels, discourage the use of tobacco
products and foods high in fat and sugar which increase the risk of chronic
diseases, and improve access to health care. Without overlooking the importance
of all these population-level measures, our work aims at enabling personalized
interventions using an algorithmic data-driven approach.
Through smart health, smart cities and governments aim at improving the
quality of life of their citizens. In the state of Massachusetts, the MassHealth
program –a combination of Medicaid and the Children’s Health Insurance Program–
provides health insurance for 1.9 million Massachusetts residents, children in
low-income households, low-wage workers, elders in nursing homes, people with
disabilities, and others with very low incomes who cannot afford insurance [7, 8].
The state’s fiscal year 2018 budget includes approximately $16.6 billion for
MassHealth, which is around 37% of the total state budget [8]. Clearly, this
is a substantial share of the budget. Consequently, if health care costs can be
lowered through smart health, more resources will become available for many
other services smart cities can offer. Conversely, if other aspects of smart cities
can be improved, the adverse health effects of urban living can be reduced, thus
lowering health care costs. This suggests a beneficial feedback loop involving
smart health and non-health-related smart city research.
Health care is also, unquestionably, an important national and global eco-
nomic issue. In 2013, the United States (U.S.) spent about $3 trillion on health
care, which exceeded 17% of its GDP [9]. The World Health Organization es-
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timates that healthcare costs will grow to 20% of the U.S. GDP (nearly $5
trillion) by 2021 [10], especially with civilization diseases (or else called lifestyle
diseases), like diabetes, coronary heart disease and obesity, growing.
Our goal in this paper is to explore and develop predictive analytics aiming
at predicting hospitalizations due to the two leading chronic diseases: heart
disease and diabetes. Prediction, naturally, is an important first step towards
prevention. It allows health systems to target individuals most in need and to
use (limited) health resources more effectively. We refer to [11] for a general
discussion of the benefits, and some risks, associated with the use of health
analytics. We seek to predict hospitalizations based on the patients’ Electronic
Health Records (EHR) within a year from the time we examine the EHR, so as to
allow enough lead time for prevention. What is also critical is that our methods
provide an interpretation (or explanation) of the predictions. Interpretability
will boost the confidence of patients and physicians in the results, hence, the
chance they will act based on the predictions, and provide insight into potential
preventive measures. It is interesting that interpretability is being increasingly
recognized as important; for instance recent European Union legislation [12] will
enforce a citizen’s right to receive an explanation for algorithmic decisions.
Our focus on heart disease and diabetes is deliberate. Diseases of the heart
have been consistently among the top causes of death. In the U.S., heart disease
is yearly the cause of one in every four deaths, which translates to 610,000
people [13]. At the same time, diabetes is recognized as the world’s fastest
growing chronic condition [14]. One in eleven adults has diabetes worldwide
(415 million) and 12% of global health expenditures is spent on diabetes ($673
billion) [15]. In the U.S. alone, 29.1 million people or 9.3% of the population
had diabetes in 2012 [16].
Our interest in hospitalizations is motivated by [17], which found that nearly
$30.8 billion in hospital care cost during 2006 was preventable. Heart diseases
and diabetes were the leading contributors accounting, correspondingly, for more
than $9 billion, or about 31%, and for almost $6 billion, or about 20%. Clearly,
even modest percentage reductions in these amounts matter.
An important enabler of our work is the increasing availability of patients’
EHRs. The digitization of patients’ records started more than two decades
ago. Widespread adoption of EHRs has generated massive datasets. 87% of
U.S. office-based physicians were using EHRs by the end of 2015, up from 42%
in 2008 [18]. EHRs have found diverse uses [19], e.g., in assisting hospital
quality management [20], in detecting adverse drug reactions [21], and in general
primary care [22].
1.1 Contributions and Organization
Our algorithmic approach towards predicting chronic disease hospitalizations
employs a variety of methods, both already well-established, as well as novel
methods we introduce, tailored to solve the specific medical problem. We for-
mulate the problem as a binary classification problem and seek to differentiate
between patients that will be hospitalized in a target year and those who will
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not. We review related work in Section 2. Section 3 explores baseline methods
that separate the two classes of samples (patients) using a single classifier. We
evaluate their performance in terms of prediction accuracy and interpretability
of the model and the results. Baseline methods include linear and kernelized
Support Vector Machines (SVM), random forests, and logistic regression. We
also develop a novel likelihood ratio-based method, K-LRT, that identifies the
K most significant features for each patient that lead to hospitalization. Sur-
prisingly, this method, under a small value of K, performs not substantially
worse than more sophisticated classifiers using all available features. This sug-
gests that in our setting, a sparse classifier employing a handful of features can
be very effective. What is more challenging is that the “discriminative” features
are not necessarily the same for each patient.
Motivated by the success of sparse classifiers, in Section 4 we seek to jointly
identify clusters of patients who share the same set of discriminative features
and, at the same time, develop per-cluster sparse classifiers using these fea-
tures. Training such classifiers amounts to solving a non-convex optimization
problem. We formulate it as an integer programming problem; which limits
its use to rather smaller instances (training sets). To handle much larger in-
stances we develop a local optimization approach based on alternating opti-
mization. We establish the convergence of this local method and bound its
Vapnik-Chervonenkis (VC) dimension; the latter bound leads to out-of-sample
generalization guarantees.
In Section 5, we provide a detailed description of the two datasets we use
to evaluate the performance of the various algorithms. One dataset concerns
patients with heart-related diseases and the other, patients with diabetes. The
data have been made available to us from the Boston Medical Center (BMC)
– the largest safety-net hospital in New England. We define the performance
metrics we use in Section 6. We report and discuss our experimental settings
and results in Section 7 and we present our conclusions in Section 8.
Notation: All vectors are column vectors. For economy of space, we write
x =
(
x1, . . . , xdim(x)
)
to denote the column vector x, where dim(x) is the di-
mension of x. We use 0 and 1 for the vectors with all entries equal to zero and
one, respectively. We denote by R+ the set of all nonnegative real numbers.
M ≥ 0 (resp., x ≥ 0) indicates that all entries of a matrix M (resp., vector x)
are nonnegative. We use “prime” to denote the transpose of a matrix or vector
and |D| the cardinality of a set D. Unless otherwise specified, ‖ · ‖ denotes the
`2 norm and ‖ · ‖1 the `1 norm.
2 Related Work
To the best of our knowledge, the problem of chronic disease hospitalization
prediction using machine learning methods is novel. A closely related problem,
which has received a lot of attention in the literature, is the re-hospitalization
prediction, since around 20% of all hospital admissions occur within 30 days
of a previous discharge. Medicare penalizes hospitals that have high rates of
4
readmissions for some specific conditions that now include patients with heart
failure, heart attack, and pneumonia. Examples of work on this problem include
[23], [24], [25] and [26].
Other related problems considered in the literature are: predicting the onset
of diabetes using artificial neural networks [27]; developing an intelligent system
that predicts, using data-mining techniques, which patients are likely to be
diagnosed with heart disease [28]; and using data-mining techniques to predict
length of stay for cardiac patients (employing decision trees, SVM, and artificial
neural networks) [29], or for acute pancreatitis (using artificial neural networks)
[30].
We should also mention the Heritage Health Prize, a competition by Kaggle,
whose goal was to predict the length of stay for patients who will be admitted
to a hospital within the next year, using insurance claims data and data-mining
techniques [31].
3 Baseline Methods and K-LRT
In this section we outline several baseline classification methods we use to predict
whether patients will be hospitalized in a target year, given their medical history.
In medical applications, accuracy is important, but also interpretability of
the predictions is indispensable [32], strengthening the confidence of medical
professionals in the results. Sparse classifiers are interpretable, since they pro-
vide succinct information on few dominant features leading to the prediction
[33]. Moreover, medical datasets are often imbalanced since there are much
fewer patients with a condition (e.g., hospitalized) vs. “healthy” individuals
(non-hospitalized). This makes it harder for supervised learning methods to
learn since a training set may be dominated by negative class samples. Spar-
sity, therefore, is useful in this context because there are fewer parameters in the
classifier one needs to learn. In this light, we experiment with sparse versions
of various classification methods and show their advantages. While harder to
interpret than linear and sparse algorithms, ensemble methods that build col-
lections of classifiers, such as random forests, can model nonlinear relationships
and have been proven to provide very accurate models for common health care
problems [34], including the one we study in this paper.
The last method we present in this section is an adaptation of a likelihood
ratio test, designed to induce sparsity of the features used to make a prediction.
All but the last method fall into the category of discriminative learning algo-
rithms, while the last one is a generative algorithm. Discriminative algorithms
directly partition the input space into label regions without modeling how the
data are generated, while generative algorithms assume a model that generates
the data, estimate the model’s parameters and use it to make classification de-
cisions. Our experiment results show that discriminative methods are likely to
give higher accuracy, but generative methods provide more interpretable models
and results [35, 36]. This is the reason we experiment with methods from both
families and the trade-off between accuracy and interpretability is observed in
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our results.
3.1 RBF, Linear & Sparse Linear Support Vector Ma-
chines
A Support Vector Machine (SVM) is an efficient binary classifier [37]. The
SVM training algorithm seeks a separating hyperplane in the feature space, so
that data points from the two different classes reside on different sides of that
hyperplane. We can calculate the distance of each input data point from the
hyperplane. The minimum over all these distances is called margin. The goal
of SVM is to find the hyperplane that has the maximum margin. In many
cases, however, data points are neither linearly nor perfectly separable. So
called soft-margin SVM, tolerates misclassification errors and can leverage kernel
functions to “elevate” the features into a higher dimensional space where linear
separability is possible (kernelized SVMs) [37].
Given our interest in interpretable, hence sparse, classifiers we formulate
a Sparse version of Linear SVM (SLSVM) as follows. We are given training
data xi ∈ RD and labels yi ∈ {−1, 1}, i = 1, . . . , n, where xi is the vector
of features for the ith patient and yi = 1 (resp., yi = −1) indicates that the
patient will (resp., not) be hospitalized. We seek to find the classifier (β, β0),
β ∈ RD, β0 ∈ R, by solving:
min
β,β0,ξi
1
2‖β‖2 + C
∑n
i=1 ξi + ρ‖β‖1
s.t. ξi ≥ 0, ∀i,
yi(x
′
iβ + β0) ≥ 1− ξi, ∀i,
(1)
where ξi is a misclassification penalty. The first term in the objective has the
effect of maximizing the margin. The second objective term minimizes the
total misclassification penalty. The last term, ‖β‖1, in the objective, imposes
sparsity in the feature vector β, thus allowing only a sparse subset of features
to contribute to the classification decision. The parameters C and ρ are tunable
parameters that control the relative importance of the misclassification and the
sparsity terms, respectively, compared to each other and, also, the margin term.
When ρ = 0, the above formulation yields a standard linear SVM classifier.
A linear SVM finds a linear hyperplane in the feature space and can not
handle well cases where a nonlinear separating surface between classes is more
appropriate. To that end, kernel functions are being used that map the fea-
tures to a higher dimensional space where a linear hyperplane would be appli-
cable. In the absence of the sparse-inducing `1-norm term, kernelized SVMs use
K(xi,xj) = φ(xi)
′φ(xi) as a kernel for some feature mapping function φ and
solve an optimization problem that is based on the dual problem to (1) to find
an optimal (β, β0). In our application, we will employ the widely used Radial
Basis Function (RBF) K(xi,xj) = exp(−‖xi − xj‖2/2σ2) [38] as the kernel
function in our experiments.
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3.2 Random Forests
Bagging (or bootstrap aggregating) is a technique for reducing the variance
of an estimated predictor by averaging many noisy but approximately unbiased
models. A random forest is an ensemble of de-correlated trees [39]. Each decision
tree is formed using a training set obtained by sampling (with replacement) a
random subset of the original data. While growing each decision tree, random
forests use a random subset of the set of features (variables) at each node split.
Essentially, the algorithm uses bagging for both trees and features. Each tree is
fully grown until a minimum size is reached, i.e., there is no pruning. While the
predictions of a single tree are highly sensitive to noise in its training set, the
average of many trees is not, as long as the trees are not correlated. Bagging
achieves de-correlating the trees by constructing them using different training
sets. To make a prediction at a new sample, random forests take the majority
vote among the outputs of the grown trees in the ensemble. Random forests run
very efficiently for large datasets, do not have the risk of overfitting (as, e.g.,
AdaBoost [40], a boosting method) and can handle datasets with imbalanced
classes. The number of trees in the ensemble is selected through cross-validation.
3.3 Sparse Logistic Regression
Logistic Regression (LR) [41] is a linear classifier widely used in many classi-
fication problems. It models the posterior probability that a patient will be
hospitalized as a logistic function of a linear combination of the input features,
with parameters θ that weigh the input features and an offset θ0. The pa-
rameters of the model are selected by maximizing the log-likelihood using a
gradient method. For the test samples, decisions are made by thresholding the
log-likelihood ratio of the positive (hospitalized) class over the negative class.
Logistic regression is popular in the medical literature because it predicts a
probability of a sample belonging to the positive class. Here, we use an `1-
regularized (sparse) logistic regression [33, 42, 43], which adds an extra penalty
term proportional to ‖θ‖1 in the log-likelihood. The motivation is to induce
sparsity, effectively “selecting” a sparse subset of features. More specifically, we
solve the following convex problem using a gradient-type method:
min
θ,θ0
∑n
i=1(− log p(yi|xi;θ, θ0)) + λ‖θ‖1 (2)
where the likelihood function is given by
p(yi = 1|xi;θ, θ0) = 1
1 + e−θ0−θ′xi
=1− p(yi = −1|xi;θ, θ0),
and λ is a tunable parameter controlling the sparsity term. Setting λ = 0, we
obtain a standard logistic regression model.
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3.4 K-Likelihood Ratio Test
The Likelihood Ratio Test (LRT) is a naive Bayes classifier and assumes that in-
dividual features (elements) of the feature vector x = (x1, . . . , xD) are indepen-
dent random variables [44]. The LRT algorithm empirically estimates the dis-
tribution p(xj |y) of each feature j for the hospitalized and the non-hospitalized
class. Given a new test sample z = (z1, z2, · · · , zD), LRT calculates the two like-
lihoods p(z|y = 1) and p(z|y = −1) and then classifies the sample by comparing
the ratio
p(z|y = 1)
p(z|y = −1) =
D∏
j=1
p(zj |y = 1)
p(zj |y = −1)
to a threshold. In our variation of the method, which we will call K-LRT, 1
instead of taking into account the ratios of the likelihoods of all features, we
consider only the K features with the largest ratios. We consider only the
largest ratios because they correspond to features with a strong hospitalization
“signal.” On the other hand, we do not consider features with the smallest
ratios because they could be due to the imbalance of the dataset which has
much more non-hospitalized than hospitalized patients.
The optimal K can be selected using cross-validation from a set of pre-
defined values, that is, as the value with the best classification performance
in a validation set. The purpose of this “feature selection” is again sparsity,
that is, to identify the K most significant features for each individual patient.
Thus, each patient is actually treated differently and this algorithm provides
interpretability as to why a specific classification decision has been made for
each individual patient.
4 Joint Clustering and Classification (JCC)
In this section, we introduce a novel Joint Clustering and Classification method.
The motivation comes from the success of K-LRT, which we will see in Sec-
tion 7. Since K-LRT selects a sparse set of features for each patient, it stands
to reason that there would be clusters of patients who share the same features.
Moreover, since K-LRT uses the K largest likelihood ratios, feature selection is
more informative for patients that are hospitalized (positive class). This is intu-
itive: patients are hospitalized for few underlying reasons while non-hospitalized
patients appear “normal” in all features associated with a potential future hos-
pitalization.
To reflect this reasoning, we consider a classification problem in which the
positive class consists of multiple clusters, whereas negative class samples form
a single cluster. It is possible to extend our framework and consider a setting
where clustering is applied to both the positive and the negative class. However,
because our results are satisfactory and to avoid further increasing complexity,
we do not pursue this direction in this work. We assume that for each (positive
1K-LRT was first proposed in [44] and was applied only to a heart-disease dataset.
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class) cluster there is a sparse set of discriminative dimensions, based on which
the cluster samples are separated from the negative class. Fig. 1 provides an
illustration of this structure. The different clusters of patients are naturally cre-
ated based on age, sex, race or different diseases. From a learning perspective, if
the hidden positive groups are not predefined and we would like to learn an op-
timal group partition in the process of training classifiers, the problem could be
viewed as a combination of clustering and classification. Furthermore, with the
identified hidden clusters, the classification model becomes more interpretable
in addition to generating accurate classification labels. A preliminary theo-
retical framework for JCC appeared in our conference paper [45], but without
containing all detailed proofs of the key technical results and with very limited
numerical evaluation.
Figure 1: The positive class contains two clusters and each cluster is linearly
separable from the negative class.
4.1 An integer programming formulation
We next consider a joint cluster detection and classification problem under a
Sparse Linear SVM (SLSVM) framework. Let x+i and x
−
j be the D-dimensional
positive and negative class data points (each representing a patient), and y+i =
1, ∀i, y−j = −1, ∀j, the corresponding labels, where i ∈ {1, 2, . . . , N+} and
j ∈ {1, 2, . . . , N−}. Assuming L hidden clusters in the positive class, we seek to
discover: (a) the L hidden clusters (denoted by a mapping function l(i) = l, l ∈
{1, 2, . . . , L}), and (b) L classifiers, one for each cluster. Let T l be a parameter
controlling the sparsity of the classifier for each cluster l. We formulate the
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Joint Clustering and Classification (JCC) problem as follows:
min
βl,βl0,l(i)
ζlj ,ξ
l
i
L∑
l=1
(
1
2‖βl‖2 + λ+
∑
i:l(i)=l
ξ
l(i)
i + λ
− N
−∑
j=1
ζlj
)
s.t.
D∑
d=1
|βld| ≤ T l, ∀l,
ξ
l(i)
i ≥ 1− y+i βl(i)0 −
D∑
d=1
y+i β
l(i)
d x
+
i,d, ∀i,
ζlj ≥ 1− y−j βl0 −
D∑
d=1
y−j β
l
dx
−
j,d, ∀j, l,
ξ
l(i)
i , ζ
l
j ≥ 0, ∀i, j, l.
(3)
In the above formulation, the margin between the two classes in cluster l is
equal to 2/‖βl‖, hence the first term in the objective seeks to maximize the
margin. The variables ξli, ζ
l
j represent misclassification penalties for the positive
and negative data points, respectively. The first constraint limits the `1 norm of
βl to induce a sparse SVM for each cluster. The second (resp., third constraint)
ensures that the positive (resp., negative) data points end up on the positive
(resp. negative) side of the hyperplane; otherwise a penalty of ξli (resp., ζ
l
j)
is imposed; these misclassification penalties are minimized at optimality. We
use different misclassification penalties for the positive and negative data points
to accommodate a potential imbalance in the training set between available
samples; typically, we have more negative (i.e., not hospitalized) samples. Notice
that the misclassification costs of the negative samples are counted L times
because they are drawn from a single distribution and, as a result, they are
not clustered but simply copied into each cluster. The parameters λ− and λ+
control the weights of costs from the negative and the positive samples.
As stated, problem (3) is not easily solvable as it combines the cluster al-
location decisions (i.e., deciding the cluster assignment l(i) for each sample i)
with the determination of the SVM hyperplanes. One approach to solve JCC
is shown below, where we transform the problem into a mixed integer program-
ming problem (MIP) by introducing binary indicator variables to represent the
cluster assignment in JCC (each positive sample can only be assigned to one
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cluster):
min
βl,βl0,zil
ζlj ,ξ
l
i
L∑
l=1
(
1
2‖βl‖2 + λ+
N+∑
i=1
ξli + λ
− N
−∑
j=1
ζlj
)
s.t.
D∑
d=1
|βld| ≤ T l, ∀l,
ξli ≥ 1− y+i βl0 −
D∑
d=1
y+i β
l
dx
+
i,d −M
∑
k 6=l
zik, ∀i, l,
ζlj ≥ 1− y−j βl0 −
D∑
d=1
y−j β
l
dx
−
j,d, ∀j, l
L∑
l=1
zil = 1, ∀i; zil ∈ {0, 1}, ∀i, l,
ξli, ζ
l
j ≥ 0,∀i, j, l,
(4)
where zil = 1 when l(i) = l and 0 otherwise (binary variables describing the
cluster assignments) and M is a large positive real number. The following
proposition establishes the equivalence between formulations (4) and (3). The
proof can be found in Appendix A.
Proposition 4.1 The MIP formulation (4) is equivalent to the original JCC
formulation (3).
In order to obtain better clustering performance, we introduce a penalty
term in the objective function seeking to minimize the intra-cluster distances
between samples, that is, making samples in the same cluster more similar to
each other. This term takes the form: ρ
∑N+
i1=1
∑N+
i2=1
σi1i2‖x+i1 − x+i2‖2, where
σi1i2 =
{
1, if x+i1 and x
+
i2
belong to the same cluster,
0, otherwise.
For σ to comply with this definition, we need to impose the constraint
zi1l + zi2l − σi1i2 ≤ 1, ∀ i1 6= i2, l and σi,j ∈ {0, 1}.
The MIP approach presented above comes in a compact form, solves jointly
the clustering and the classification problem, and exhibits good performance on
small-scale problems. However, there are no general polynomial-time algorithms
for solving MIPs, thus, making it problematic for large datasets that are most
common in practice. This motivates us to develop the following Alternating
Clustering and Classification (ACC) approach, which does not suffer from these
limitations.
4.2 An alternating optimization approach
The idea behind ACC is to alternately train a classification model and then re-
cluster the positive samples, yielding an algorithm which scales well and also,
as we will see, comes with theoretical performance guarantees.
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Given cluster assignments l(i) for all positive training samples i, the JCC
problem (3) can be decoupled into L separate quadratic optimization prob-
lems, essentially solving an SVM training problem per cluster. Our alternating
optimization approach, summarized in Algorithms 1–2, consists of two major
modules: (i) training a classifier for each cluster and (ii) re-clustering positive
samples given all the estimated classifiers.
The process starts with an initial (e.g., random or using some clustering al-
gorithm) cluster assignment of the positive samples and then alternates between
the two modules. Algorithm 1 orchestrates the alternating optimization process;
given samples’ assignment to clusters, it obtains the optimal per-cluster SLSVM
classifiers and calls the re-clustering procedure described in Algorithm 2.
Algorithm 2 uses the computed L classifiers and assigns a positive sample
i to the cluster l whose classification hyperplane is the furthest away from the
sample i, that is, whose classifier better separates sample i from the negative
class. Notice that the re-clustering of the positive samples is based on C, a subset
of {1, . . . , D}, which is a set of selected features that allows us to select which
features are important in cluster discrimination so that the identified clusters
are more interpretable. In a notational remark, we denote x+i,C (resp., xC) as
the projection of the D-dimensional feature vector x+i (resp., x) on the subset
C. We also impose the constraint (5) in Algorithm 2, which is necessary for
proving the convergence of ACC.
Algorithm 1 ACC Training
Initialization:
Randomly assign positive class sample i to cluster l(i), for i ∈ {1, . . . , N+}
and l(i) ∈ {1, . . . , L}.
repeat
Classification Step:
Train an SLSVM classifier for each cluster of positive samples combined
with all negative samples. Each classifier is the outcome of a quadratic
optimization problem (cf. (11)) and provides a hyperplane perpendicular
to βl and a corresponding optimal objective value Ol.
Re-clustering Step:
Re-cluster the positive samples based on the classifiers βl and update the
l(i)’s.
until no l(i) is changed or
∑
lO
l is not decreasing.
Finally, Algorithm 3 describes how ACC classifies new samples not used in
training. Specifically, it assigns a new sample to the cluster whose classifier is
furthest away from that sample and uses the classifier of that cluster to make
the classification decision.
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Algorithm 2 Re-clustering procedure given classifiers
Input: positive samples x+i , classifiers β
l, current cluster assignment which
assigns sample i to cluster l(i).
for all i ∈ {1, . . . , N+} do
for all l ∈ {1, . . . , L} do
calculate the projection ali of positive sample i onto the classifier for
cluster l using only elements in a feature set C: ali = x+i,C
′
βlC ;
end for
update cluster assignment of sample i from l(i) to
l∗(i) = arg max
l
ali, subject to
x+i
′
βl
∗(i) + β
l∗(i)
0 ≥ x+i
′
βl(i) + β
l(i)
0 . (5)
end for
Algorithm 3 ACC Testing
for each test sample x do
Assign it to cluster l∗ = arg max
l
xC
′
βlC .
Classify x with βl
∗
.
end for
4.3 ACC performance and convergence guarantees
In this subsection, we rigorously prove ACC convergence and establish out-of-
sample (in a “test” set not seen during training) performance guarantees. While
theoretical, such results are important because (i) they establish that ACC will
converge to a set of clusters and a classifier per cluster and (ii) characterize
the number of samples needed for training, as well as (iii) bound out-of-sample
classification performance in terms of the in-sample performance.
We first present a result that suggests a favorable sample complexity for
SLSVM compared to the standard linear SVM. Suppose that SLSVM for the l-th
cluster yields Ql < D non-zero elements of βl, thus, selecting a Ql-dimensional
subspace of features used for classification. The value of Ql is controlled by the
parameter T l (cf. (4)).
As is common in the learning literature [46], we draw independent and iden-
tically distributed (i.i.d.) training samples from some underlying probability
distribution. Specifically, we draw N− negative samples from some distribution
P0 and N+l positive samples for cluster l from some distribution P l1, where the
total number of positive and negative samples used to derive the classifier of
cluster l is N l = N+l + N
−. Let RlN l denote the expected training error rate
and Rl the expected test error (out-of-sample) for the classifier of cluster l under
these distributions. The proof of the following result is in Appendix B. We note
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that e in (6) is the base of the natural logarithm.
Theorem 4.2 For a specific cluster l, suppose that the corresponding sparse lin-
ear SVM classifier lies in a Ql-dimensional subspace of the original D-dimensional
space. Then, for any  > 0 and δ ∈ (0, 1), if the sample size N l satisfies
N l ≥ 8
2
[
log
2
δ
+ (Ql + 1) log
2eN l
Ql + 1
+Ql log
eD
Ql
]
, (6)
it follows that with probability no smaller than 1− δ, Rl −RlN l ≤ .
Theorem 4.2 suggests that if the training set contains a number of samples
roughly proportional to (Ql + log(1/δ))/2, then we can guarantee with proba-
bility at least 1− δ an out-of-sample error rate -close to the training error rate.
In other words, sparse SVM classification requires samples proportional to the
effective dimension of the sparse classifier and not the (potentially much larger)
dimension D of the feature space.
Next we establish that the ACC training algorithm converges. The proof
is given in Appendix C. As a remark on convergence, it is worth mentioning
that the values λ+ and λ− should be fixed across all clusters to guarantee
convergence.
Theorem 4.3 The ACC training algorithm (Alg. 1) converges for any set C.
The following theorem establishes a bound on the VC-dimension of the class
of decision functions produced by ACC training. As we will see, this bound will
then lead to out-of-sample performance guarantees. To state the result, let us
denote by H the family of clustering/classification functions produced by ACC
training. The proof of the following theorem is in Appendix D.
Theorem 4.4 The VC-dimension of H is bounded by
VACC
4
= (L+ 1)L(D + 1) log
(
e
(L+ 1)L
2
)
.
Theorem 4.4 implies that the VC-dimension of ACC-based classification grows
linearly with the dimension of data samples and polynomially (between quadratic
and cubic) with the number of clusters. Since the local (per cluster) classifiers
are trained under an `1 constraint, they are typically defined in a lower dimen-
sional subspace. At the same time, the clustering function also lies in a lower
dimensional space C. Thus, the “effective” VC-dimension could be smaller than
the bound in Theorem 4.4.
An immediate consequence of Thm. 4.4 is the following corollary which es-
tablishes out-of-sample generalization guarantees for ACC-based classification
and is based on a result in [47] (see also Appendix B). To state the result, let
N = N+ +N− the size of the training set. Let RN denote the expected train-
ing error rate and R the expected test error (out-of-sample) of the ACC-based
classifier.
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Corollary 4.5 For any ρ ∈ (0, 1), with probability at least 1− ρ it holds:
R ≤ RN + 2
√
2
VACC log
2eN
VACC
+ log 2ρ
N
.
5 The Data
The data we use to evaluate the various methods we presented come from the
Boston Medical Center (BMC). BMC is the largest safety-net hospital in New
England and with 13 affiliated Community Health Centers (CHCs) provides
care for about 30% of Boston residents. The data integrate information from
hospital records, information from the community health centers, and some
billing records, thus forming a fairly rich and diverse dataset.
The study is focused on patients with at least one heart-related diagnosis
or procedure record in the period 01/01/2005–12/31/2010 or a diagnosis record
of diabetes mellitus between 01/01/2007–12/31/2012. For each patient in the
above set, we extract the medical history (demographics, hospital/physician
visits, problems, medications, labs, procedures and limited clinical observa-
tions) for the period 01/01/2001–12/31/2010 and 01/01/2001–12/31/2012, cor-
respondingly, which includes relevant medical factors from which we will con-
struct a set of patient features. Data were available both from the hospital
EHR and billing systems. Table 1 shows the ontologies, along with the num-
ber of factors and some examples corresponding to each of the heart patients.
Similarly, Table 2 shows the ontologies with some examples for the diabetic
patients. In these tables, ICD9 (International Classification of Diseases, 9th re-
vision) [48], CPT (Current Procedural Terminology) [49], LOINC (Logical Ob-
servation Identifiers Names and Codes) [50], and MSDRG (Medicare Severity-
Diagnosis Related Group) [51] are commonly used medical coding systems for
diseases, procedures, laboratory observations, and diagnoses, respectively.
We note that some of the diagnoses and admissions in Table 1 are not directly
heart-related, but may be good indicators of a heart problem. Also, as expected,
many of the diagnoses and procedures in Table 2 are direct complications due
to diabetes. Diabetes-related admissions are not trivially identifiable, and are
revealed through the procedure described in the next subsection. Overall, our
heart dataset contains 45,579 patients and our diabetes dataset consists of 33,122
patients after preprocessing, respectively. Among these patients, 3,033 patients
in the heart dataset and 5,622 patients in the diabetes dataset are labeled as
hospitalized in a target year. For each dataset we randomly select 60% of the
patients for training and keep the remaining 40% of the patients for testing.
Our objective is to leverage past medical factors for each patient to predict
whether she/he will be hospitalized or not during a target year which, as we
explain below, could be different for each patient.
In order to organize all the available information in a uniform way for all
patients, some preprocessing of the data is needed to summarize the information
over a time interval. Details will be discussed in the next subsection. We will
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refer to the summarized information of the medical factors over a specific time
interval as features.
Each feature related to diagnoses, procedures (CPT), procedures (ICD9)
and visits to the Emergency Room is an integer count of such records for a spe-
cific patient during the specific time interval. Zero indicates the absence of any
record. Blood pressure and lab tests features are continuous valued. Missing
values are replaced by the average of values of patients with a record at the
same time interval. Features related to tobacco use are indicators of current-
or past-smoker in the specific time interval. Admission features contain the
total number of days of hospitalization over the specific time interval the fea-
ture corresponds to. Admission records are used both to form the admission
features (past admission records) and in order to calculate the prediction vari-
able (existence of admission records in the target year). We treat our problem
as a classification problem and each patient is assigned a label: 1 if there is
a heart-related (or diabetes-related) hospitalization in the target year and −1
otherwise.
5.1 Heart Data Preprocessing
In this section we discuss several data organization and preprocessing choices
we make for the heart dataset. For each patient, a target year is fixed (the year
in which a hospitalization prediction is sought) and all past patient records are
organized as follows.
5.1.1 Summarization of the medical factors in the history of a pa-
tient
After exploring multiple alternatives, an effective way to summarize each pa-
tient’s medical history is to form four time blocks for each medical factor. Time
blocks 1, 2, and 3 summarize the medical factors over one, two, and three years
before the target year, whereas the 4th block summarizes all earlier patient
records. For tobacco use, there are only two features, indicating whether the
patient is currently smoking and whether he/she has ever smoked. After remov-
ing features with zero standard deviation, this process results in a vector of 212
features for each patient.
5.1.2 Selection of the target year
As a result of the nature of the data, the two classes are highly imbalanced.
When we fix the target year for all patients to be 2010, the number of hospital-
ized patients is about 2% of the total number of patients, which does not yield
enough positive samples for effective training. Thus, and to increase the num-
ber of hospitalized patient examples, if a patient had only one hospitalization
throughout 2007–2010, the year of hospitalization is set as the target year for
that patient. If a patient had multiple hospitalizations, a target year between
the first and the last hospitalization is randomly selected.
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5.1.3 Setting the target time interval to be a year
After testing several options, a year appears to be an appropriate time interval
for prediction. Shorter prediction windows increase variability and do not al-
low sufficient time for prevention. Moreover, given that hospitalization occurs
roughly uniformly within a year, we take the prediction time interval to be a
calendar year.
5.1.4 Removing noisy samples
Patients who have no records before the target year are impossible to predict
and are thus removed.
5.2 Identifying Diabetes-Related Hospitalizations
Identifying the hospitalizations that occur mainly due to diabetes is not a trivial
task, because for financial reasons (i.e., higher reimbursement) many diabetes-
related hospitalizations are recorded in the system as other types of admissions,
e.g., heart-related. Therefore, as a first step, we seek to separate diabetes-
related admissions from all the rest. To that end, we consider all patients with
at least one admission record between 1/1/2007 and 12/31/2012. From this
set, patients with at least one diabetes mellitus record during the same period
are assigned to the diabetic population, while the rest are assigned to the non-
diabetic population.
We list the union of all unique admission types for both populations (732
unique types). The total number of admission samples for the diabetic and
non-diabetic populations are N1 = 47, 352 and N2 = 116, 934, respectively. For
each type of admission d, each admission sample can be viewed as the outcome
of a binary random variable that takes the value 1, if the hospitalization occurs
because of this type of admission, and 0, otherwise. Thus, we can transform
the two sets of admission records for the two populations into binary (0/1)
sequences. By (statistically) comparing the proportions of d in the two pop-
ulations, we can infer whether admission d was caused mainly by diabetes or
not.
To that end, we will utilize a statistical hypothesis test comparing sample
differences of proportions. Suppose we generate two sets of admissions S1 and
S2 of size N1 and N2 drawn from the diabetic and the non-diabetic patient
populations, respectively. Consider a specific admission type d and suppose
that it appears with probability p1, out of all possible admission types in S1.
Similarly, a type d admission appears with probability p2 in S2. Given now the
two sets of admissions from diabetics (S1) and non-diabetics (S2), let P1 and
P2 be the corresponding sample proportions of type d admissions. We want
to statistically compare P1 and P2 and assess whether a type d admission is
more prevalent in S1 vs. S2. Consider as the null hypothesis the case where
p1 = p2, i.e., a type d admission is equally likely in the two populations. Under
the null hypothesis, the sampling distribution of differences in proportions is
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approximately normally distributed, with its mean and standard deviation given
by
µP1−P2 = 0 and σP1−P2 =
√√√√pq( 1
N1
+
1
N2
)
,
where p = (N1P1+N2P2)/(N1+N2) is used as an estimate of the probability of a
type d admission in both populations and q = 1− p. By using the standardized
variable z = (P1 − P2)/(σP1−P2) we can assess if the results observed in the
samples differ markedly from the results expected under the null hypothesis.
We do that using the single sided p-value of the statistic z. The smaller the
p-value is, the higher the confidence we have in the alternative hypothesis or
equivalently in the fact that the diabetic patients have higher chance of getting
admission records of type d than the non-diabetic ones (since we consider the
difference P1−P2). We list admission types in increasing order of p-value and we
set a threshold of p-value ≤ α = 0.0001; admission types with p-value less than
α are considered to be attributed to diabetes. 2 Examples of diabetes-related
admissions are shown in Table 2.
5.3 Diabetes Data Preprocessing
The features are formed as combinations of different medical factors (instead of
considering the factors as separate features) that better describe what happened
to the patients during their visits to the hospital. Specifically, we form triplets
that consist of a diagnosis, a procedure (or the information that no procedure
was done), and the service department. An example of a complex feature (a
triplet) is the diagnosis of ischemic heart disease that led to an adjunct vascular
system procedure (procedure on single vessel) while the patient was admitted to
the inpatient care. Clearly, since each category can take one of several discrete
values, a huge number of combinations should be considered. Naturally, not
all possible combinations occur, which reduces significantly the total number
of potential features that describe each patient. Also for each patient, we ex-
tract information about the diabetes type over their history and demographics
including age, gender and race. Next, we present several data organization and
preprocessing steps we take. For each patient, a target year is fixed and all past
patient records are organized as follows.
5.3.1 Forming the complex features
We create a diagnoses-procedures indicator matrix to keep track of which diag-
nosis occurs with which procedure. The procedures that are not associated with
any diabetes-related diagnosis are removed. Procedures in the dataset are listed
in the most detailed level of the ICD9 coding system [48] or the CPT coding
2Apart from selecting a small-value α, we also ensure that the cumulative fraction of
patients that are potentially labeled as belonging to the hospitalized class is not too small, so
that the dataset is not highly imbalanced.
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system [49]. We group together procedures that belong to the same ICD9/CPT
family, resulting in 31 categories (out of 2004 in total).
5.3.2 Summarization of the complex features in the history of a
patient
We use the same approach as with heart diseases: we form four time blocks for
each medical factor with all corresponding records summarized over one, two,
three years before the target year, and a fourth time block containing averages
of all the earlier records. This produces a 9, 402-dimensional vector of features
characterizing each patient.
5.3.3 Reducing the number of features
We remove all the features that do not contain enough information for a signifi-
cant amount of the population (less than 1% of the patients), as they could not
help us generalize. This leaves 320 medical and 3 demographical features.
5.3.4 Identifying the diabetes type
The ICD9 code for diabetes is assigned to category 250 (diabetes mellitus). The
fifth digit of the diagnosis code determines the type of diabetes and whether it is
uncontrolled or not stated as uncontrolled. Thus, we have four types of diabetes
diagnoses: type II, not stated as uncontrolled (fifth digit 0), type I, not stated
as uncontrolled (fifth digit 1), type II or unspecified type, uncontrolled (fifth
digit 2) and type I, uncontrolled (fifth digit 3). Based on these four types, we
count how many records of each type each patient had in the four time blocks
before the target year, thus adding 16 new features for each patient.
5.3.5 Setting the target time interval to a calendar year
Again, as with heart diseases, we seek to predict hospitalizations in the target
time interval of a year starting on the 1st of January and ending on the 31st of
December.
5.3.6 Selection of the target year
As a result of the nature of the data, the two classes are highly imbalanced. To
increase the number of hospitalized patient examples, if a patient had only one
hospitalization throughout 2007–2012, the year of hospitalization will be set as
the target year. If a patient had multiple hospitalizations, a target year between
the first and the last hospitalizations will be randomly selected. 2012 is set as
the target year for patients with no hospitalization, so that there is as much
available history for them as possible. By this policy, the ratio of hospitalized
patients in the dataset is 16.97%.
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5.3.7 Removing patients with no record
Patients who have no records before the target year are removed, since there is
nothing on which a prediction can be based. The total number of patients left
is 33,122.
5.3.8 Splitting the data into a training set and a test set randomly
As is common in supervised machine learning, the population is randomly split
into a training and a test set. Since from a statistical point of view, all the data
points (patients’ features) are drawn from the same distribution, we do not
differentiate between patients whose records appear earlier in time than others
with later time stamps. A retrospective/prospective approach appears more
often in the medical literature and is more relevant in a clinical trial setting,
rather than in our algorithmic approach. What is critical in our setting is that
for each patient prediction we make (hospitalization/non-hospitalization in a
target year), we only use that patients’ information before the target year.
6 Performance Evaluation
Typically, the primary goal of learning algorithms is to maximize the prediction
accuracy or equivalently minimize the error rate. However, in the specific medi-
cal application problem we study, the ultimate goal is to alert and assist patients
and doctors in taking further actions to prevent hospitalizations before they oc-
cur, whenever possible. Thus, our models and results should be accessible and
easily explainable to doctors and not only machine learning experts. With that
in mind, we examine our models from two aspects: prediction accuracy and
interpretability.
The prediction accuracy is captured in two metrics: the false alarm rate
(how many patients were predicted to be in the positive class, i.e., hospitalized,
while they truly were not) and the detection rate (how many patients were
predicted to be hospitalized while they truly were). In the medical literature,
the detection rate is often referred to as sensitivity and the term specificity is
used for one minus the false alarm rate. Two other terms that are commonly
used are the recall rate, which is the same as the detection rate, and the precision
rate, which is defined as the ratio of true positives (hospitalizations) over all
the predicted positives (true and false). For a binary classification system, the
evaluation of the performance is typically illustrated with the Receiver Operating
Characteristic (ROC) curve, which plots the detection rate versus the false
alarm rate at various threshold settings. To summarize the ROC curve and be
able to compare different methods using only one metric, we will use the Area
Under the ROC Curve (AUC). An ideal classifier achieves an AUC equal to 1
(or 100%), while a classifier that makes random classification decisions achieves
an AUC equal to 0.5 (or 50%). Thus, the “best” (most accurate) classification
method will be the one that achieves the highest AUC.
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For the heart study we conduct, we will also generate the ROC curve based
on patients’ 10-year risk of general cardiovascular disease derived by the Fram-
ingham Heart Study (FHS) [52]. FHS is a seminal study on heart diseases that
has developed a set of risk factors for various heart problems. The 10-year risk
we are using is the closest to our purpose and has been widely used. It uses the
following features (predictors): age, diabetes, smoking, treated and untreated
systolic blood pressure, total cholesterol, High-Density Lipoprotein (HDL), and
BMI (Body Mass Index) which can be used to replace lipids in a simpler model.
We calculate this risk value (which we call the Framingham Risk Factor-FRF )
for every patient and make the classification based on this risk factor only. We
also generate an ROC curve by applying random forests just to the features
involved in FRF. The generated ROC curve serves as a baseline for comparing
our methods to classifiers that are based on features suggested only by medical
intuition.
For the diabetes study, we also consider baseline classifiers that are based
only on features commonly considered by physicians. More specifically, the
features we select are: age, race, gender, average over the entire patient history
of the hemoglobin A1c, or HbA1c for short (which measures average blood sugar
concentrations for the preceding two to three months), and the average number
of emergency room visits over the entire patient history. All these features are
part of a 3-year risk of diabetes metric in [53]. We apply random forests to just
these features to obtain a baseline to compare our methods against.
Let us also note that we will compare our new algorithm ACC to SVMs
(linear and RBF), and two other hierarchical approaches that combine clus-
tering with classification, to which we refer as Cluster-Then-Linear-SVM (CT-
LSVM) and Cluster-Then-Sparse-Linear-SVM (CT-SLSVM). Specifically, CT-
LSVM first clusters the positive samples (still based on the feature set C) with
the widely used k-means method [39], then copies negative samples into each
cluster, and finally trains classifiers with linear SVM for each cluster. The only
difference between algorithm CT-SLSVM and CT-LSVM is that CT-SLSVM
adopts sparse linear SVM in the last step.
Notice that ACC implements an alternating procedure while CT-LSVM, CT-
SLSVM do not. With only one-time clustering, CT-LSVM and CT-SLSVM cre-
ate unsupervised clusters without making use of the negative samples, whereas
ACC is taking class information and classifiers under consideration so that the
clusters also help the classification.
7 Experimental Results
In this section, we will present experimental results on the two datasets for all
methods we have presented so far, in terms of both accuracy and interpretability.
For SVM, tuning parameters are the misclassification penalty coefficient
C (cf. (1)) and the kernel parameter σ; we used the values {0.3, 1, 3} and
{0.5, 1, 2, 7, 15, 25, 35, 50, 70, 100}, respectively. Optimal values of 1 and 7, re-
spectively, were selected by cross-validation.
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For K-LRT, we quantize the data as shown in Table 3. After experimenta-
tion, the best performance of K-LRT is achieved by setting k = 4.
In Figures 2 and 3, we present the ROC curves of all methods, for a particular
random split of the data into a training and test set. In Tables 4 and 5, we
present the average (avg.) and the standard deviation (std) of the AUC over 10
different splits of the data into a training and a test set. In these tables, Lin. and
RBF SVM correspond to SVM with a linear and an RBF kernel, respectively.
Sparse LR corresponds to sparse logistic regression (cf. Sec. 3.3). FRF 10-
yr risk corresponds to thresholding the Framingham 10-year risk and random
forests on FRF features simply trains a random forest on the features used in
the Framingham 10-year risk. We also report the baseline diabetes method we
presented in the previous subsection in the last row of Table 5.
Figure 2: ROC curves for the heart data.
Based on the results, random forests perform the best followed by our ACC.
It is interesting that using features selected by physicians (as in FRF or the
diabetes baseline method) leads to significantly inferior performance even if a
very sophisticated classifier (like random forests) is being used. This suggests
that the most intuitive medical features do not contain all the information that
could be used in making an accurate prediction.
In terms of interpretability, with RBF SVM, the features are mapped through
a kernel function from the original space into a higher-dimensional space. This,
however, makes the features in the new space not interpretable. Random forests
are also not easy to interpret. While a single tree classifier which is used as the
base learner is explainable, the weighted sum of a large number of trees makes
it relatively complicated to find the direct attribution of each feature to the
final decision. LRT itself lacks interpretability, because we have more than 200
features for each sample and there is no direct relationship between prediction
of hospitalization and the reasons that led to it. On the other hand, sparse
linear SVM (SLSVM which coincides with ACC using L = 1 cluster), ACC, K-
LRT, and sparse LR are easily interpretable because they are based on sparse
classifiers involving relatively few features. ACC, in addition, clusters patients
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Figure 3: ROC curves for diabetes data.
and cluster membership provides extra interpretation.
Our modified LRT, K-LRT, is particularly interpretable and it is surprising
that such a simple classifier has strong performance. It highlights the top K
features that lead to the classification decision. These features could be of
help in assisting physicians reviewing the patient’s EHR profile and formulating
hospitalization-prevention strategies. To provide an example of intuition that
can be gleaned from this information, we consider the heart disease dataset
and in Table 6 we present the features highlighted by 1-LRT. We remind the
reader that in 1-LRT, each test patient is essentially associated with a single
feature. For each feature j, we (i) count how many times it was selected as the
primary feature in the test set, and (ii) calculate the average likelihood ratio
p(zj |y = 1)/p(zj |y = −1) over all test patients. We normalize both quantities
(i) and (ii) to have zero mean and variance equal to 1. The average of these
two normalized quantities is treated as the importance score of the feature j.
We rank the importance scores and report the top 10 features in Table 6. In the
table, CPK stands for creatine phosphokinase, an enzyme which, when elevated,
it indicates injury or stress to the heart muscle tissue, e.g., as a result of a
myocardial infarction (heart attack). It is interesting that in addition to heart-
related medical factors, utilization features such as lab tests and emergency
room visits, contribute to the classification decision. This is likely the reason
why our methods, which use the entirety of the EHR, perform much better than
the Framingham-based methods.
To interpret the clusters generated by ACC for the heart study (for the case
L = 3 which yields the best performance), we plot in Figure 4 the mean value
over each cluster of each element in the feature vector xC . The 3 clusters are
well-separated. Cluster 2 contains patients with other forms of chronic ischemic
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disease (mainly coronary atherosclerosis) and myocardial infarction that had
occurred sometime in the past. Cluster 3 contains patients with dysrhythmias
and heart failure. Cardiologists would agree that these clusters contain patients
with very different types of heart disease. Finally, Cluster 1 contains all other
cases with some peaks corresponding to endocardium/pericardium disease. It
is interesting, and a bit surprising, that ACC identifies meaningful clusters of
heart-disease even though it is completely agnostic of medical knowledge.
Figure 4: Average feature values in each cluster (L = 3) for the heart diseases
dataset.
In the diabetes dataset, best ACC performance is obtained for L = 1 (a
single cluster). Still, it is of interest to examine whether meaningful clusters
emerge for L > 1. We plot again in Figure 5 the mean value over each cluster of
each element in the feature vector, using as “diagnostic” features the subset of
features which have a correlation larger than 0.01 with the labels in the training
set. This is done for a single repetition of the experiment and L = 3, yield-
ing interesting clusters and highlighting the interpretative power of ACC. We
observe that Cluster 1 contains diabetes patients with chronic cerebrovascular
disease, skin ulcers, hypertension, an abnormal glucose tolerance test, and other
complications as a result of diabetes. Cluster 2 contains patients with diabetes
complicating pregnancy. Cluster 3 contains patients with less acute disease,
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combining diabetes with hypertension. The feature values of these three clus-
ters clearly separate from the feature values in the negative class.
Figure 5: Average feature values in each cluster (L = 3) for the diabetes dataset.
8 Conclusions
In this paper, we focused on the challenge of predicting future hospitalizations
for patients with heart problems or diabetes, based on their Electronic Health
Records (EHRs). We explored a diverse set of methods, namely kernelized,
linear and `1-regularized linear Support Vector Machines, `1-regularized logis-
tic regression and random forests. We proposed a likelihood ratio test-based
method, K-LRT, that is able to identify the K most significant features for
each patient that lead to hospitalization.
Our main contribution is the introduction of a novel joint clustering and
classification method that discovers hidden clusters in the positive samples (hos-
pitalized) and identifies sparse classifiers for each cluster separating the posi-
tive samples from the negative ones (non-hospitalized). The joint problem is
non-convex (formulated as an integer optimization problem); still we developed
25
an alternating optimization approach (termed ACC) that can solve very large
instances. We established the convergence of ACC, characterized its sample
complexity, and derived a bound on VC dimension that leads to out-of-sample
performance guarantees.
For all the methods we proposed, we evaluated their performance in terms
of classification accuracy and interpretability, an equally crucial criterion in the
medical domain. Our ACC approach yielded the best performance among meth-
ods that are amenable to an interpretation (or explanation) of the prediction.
Our findings highlight a number of important insights and opportunities
by offering a more targeted strategy for “at-risk” individuals. Our algorithms
could easily be applied to care management reports or EHR-based prompts and
alerts with the goal of identifying individuals who might benefit from additional
care management and outreach. Depending on available resources and economic
considerations, a medical facility can select a specific point on the ROC curve
to operate at. This is equivalent to selecting a tolerable maximum false positive
(alarm) rate, or, equivalently, a minimum specificity. Because costs associated
with preventive actions (such as tests, medications, office visits) are orders of
magnitude lower than hospitalization costs, one can tolerate significant false
alarm rates and still save a large amount of money in preventable hospitaliza-
tion costs. To get a sense of this difference, the average cost per hospital stay
in the U.S. was $9,700 in 2010 [54], with some heart related hospitalizations
costing much more on average (e.g., $18,200 for Acute Myocardial Infarction).
In contrast, an office visit costs on the order of $200, tests like an ECG or an
echo on the order of $100-$230, and a 90-day supply of common medication
(hypertension or cholesterol) no more than $50. Clearly, even a small fraction
of prevented hospitalizations can lead to large savings. Our methods can be
seen as enabling such prevention efforts.
A Proof of Proposition 4.1
Proof: Let C∗JCC and C
∗
MIP be the optimal objective values of problems (3)
and (4).
Given any feasible solution to the JCC problem (3): l(i),βl, βl0, ζ
l
i ,∀l, i, and
ξli,JCC(i), a feasible solution to the MIP problem is:
zil =
{
1, l(i) = l,
0, otherwise,
ξli,MIP =
{
ξli,JCC , l(i) = l,
0, otherwise;
and βl, βl0, ζ
l
i remain the same as in the JCC solution.
The feasibility of the constructed MIP solution is verified as follows. No-
tice that except for the 2nd constraint in the MIP formulation (4) (the big-
M constraint), all other constraints can be easily verified to be satisfied by
the constructed MIP solution. For the big-M constraint, if zil = 1, then
M
∑
k 6=l zik = 0, and the big-M constraint holds since ξ
l
i,MIP = ξ
l
i,JCC . If,
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however, zil = 0, then M
∑
k 6=l zik = M, and the big-M constraint also holds
(trivially).
The above two feasible solutions have the same objective values, and this
equality holds for any feasible solution to the JCC problem, hence we can con-
clude that C∗JCC ≥ C∗MIP .
Next, we prove that each optimal solution to the MIP problem satisfies
ξli,MIP = 0 when zil = 0. Note that when zil = 0, M
∑
k 6=l zik = M, and the
big-M constraint becomes ξli,MIP ≥ 1− y+i βl0−
∑D
d=1 y
+
i β
l
dx
+
i,d−M , which will
always hold since M is a large enough number. Therefore, to minimize the
objective, the optimal solution should select the smallest feasible ξli,MIP , i.e.,
ξli,MIP = 0.
Given an optimal solution to the MIP problem, a corresponding feasible
solution to JCC problem is: if zil = 1, then ξ
l
i,JCC = ξ
l
i,MIP , and l(i) = l;
and all other variables retain their values in the MIP solution. Since the two
solutions have the same objective cost, it follows C∗JCC ≤ C∗MIP .
B Proof of Theorem 4.2
Proof: To simplify notation we drop the cluster index l. We will use a result
from [47]. We note that the family of linear classifiers in a D-dimensional space
has VC-dimension D+ 1 ([35]). Let G be a function family with VC-dimension
D + 1. Let RN (g) denote the training error rate of classifier g on N training
samples randomly drawn from an underlying distribution P. Let R(g) denote
the expected test error of g with respect to P. The following theorem from [47]
is useful in establishing our result.
Theorem B.1 ([47]) If the function family G has VC-dimension D + 1, then
the probability
P
R(g)−RN (g) ≤ 2
√
2
(D + 1) log 2eND+1 + log
2
ρ
N

≥ 1− ρ (7)
for any function g ∈ G and ρ ∈ (0, 1).
For the given  in the statement of Theorem 4.2, select large enough N such
that
 ≥ 2
√
2
(D + 1) log 2eND+1 + log
2
ρ
N
,
or
2
ρ
≤ exp
{
N2
8
− (D + 1) log
(
2eN
D + 1
)}
. (8)
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It follows from Thm. B.1,
P [R(g)−RN (g) ≥ ] ≤ ρ. (9)
In our setting, the classifier g is restricted to a Q-dimensional subspace of the
D-dimensional feature space. Thus, the bound in (8) holds by replacing D with
Q in the right hand side and the bound in (9) holds for any such Q-dimensional
subspace selected by the `1-penalized optimization. Since there are
(
D
Q
)
possible
choices for the subspace, using the union bound we obtain:
P [R(g)−RN (g) ≥ ] ≤
(
D
Q
)
ρ.
Using the bound
(
D
Q
) ≤ ( eDQ )Q = exp(Q log eDQ ), it follows:
P [R(g)−RN (g) ≥ ] ≤ ρ exp
{
Q log
eD
Q
}
. (10)
For the given δ ∈ (0, 1) in the statement of Theorem 4.2, select small enough ρ
such that
δ ≥ ρ exp
{
Q log
eD
Q
}
,
or equivalently
1
δ
≤ 1
ρ
exp
{
−Q log eD
Q
}
.
Using (8) (with Q replacing D), we obtain
log
2
δ
≤ N
2
8
− (Q+ 1) log
(
2eN
Q+ 1
)
−Q log eD
Q
,
which implies that N must be large enough to satisfy
N ≥ 8
2
[
log
2
δ
+ (Q+ 1) log
2eN
Q+ 1
+Q log
eD
Q
]
.
This establishes P (R(g)−RN (g) ≥ ) ≤ δ, which is equivalent to Theorem 4.2.
C Proof of Theorem 4.3
Proof: At each alternating cycle, and for each cluster l, we train a SLSVM
using as training samples the positive samples of that cluster combined with
all negative samples. This produces an optimal value Ol for the corresponding
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SLSVM training optimization problem (cf. (3)) and the corresponding classifier
(βl, βl0). Specifically, the SLSVM training problem for cluster l is:
Ol = minβl,βl0,
ζlj ,ξ
l
i
1
2 ||βl||2 + λ+
∑N+l
i=1 ξ
l
i + λ
− N
−∑
j=1
ζlj
s.t. ξli ≥ 1− y+i βl0 −
∑D
d=1 y
+
i β
l
dx
+
i,d, ∀i,
ζlj ≥ 1− y−j βl0 −
∑D
d=1 y
−
j β
l
dx
−
j,d, ∀j,∑D
d=1 |βld| ≤ T l, ξli, ζlj ≥ 0, ∀i, j.
(11)
Set
Z =
L∑
l=1
Ol =
L∑
l=1
(
1
2
||βl||2 + λ−
N−∑
j=1
ζlj
)
+ λ+
N+∑
i=1
ξ
l(i)
i ,
where l(i) maps sample i to cluster l(i),
∑L
l=1N
+
l = N
+, and βl, βl0, ζ
l
j , and
ξ
l(i)
i are optimal solutions of (11) for each l. Let us now consider the change of
Z at each iteration of the ACC training procedure.
First, we consider the re-clustering step (Alg. 2) given computed SLSVMs
for each cluster. During the re-clustering step, the classifier and slack variables
for negative samples are not modified. Only the ξ
l(i)
i get modified since the
assignment functions l(i) change. When we switch positive sample i from cluster
l(i) to l∗(i), we can simply assign value ξl(i)i to ξ
l∗(i)
i . Therefore, the value of Z
does not change during the re-clustering phase and takes the form
Z =
L∑
l=1
(
1
2
||βl||2 + λ+
∑
{i:l∗(i)=l}
ξli + λ
−
N−∑
j=1
ζlj
)
.
Next, given new cluster assignments, we re-train the local classifiers by re-
solving problem (11) for each cluster l. Notice that re-clustering was done
subject to the constraint in Eq. (5). Since y+i = 1 for all positive samples, we
have
ξ
l(i)
i ≥1− βl(i)0 −
D∑
d=1
β
l(i)
d x
+
i,d
≥1− βl∗(i)0 −
D∑
d=1
β
l∗(i)
d x
+
i,d.
The first inequality is due to ξ
l(i)
i being feasible for (11). The second inequality
is due to y+i = 1 and Eq. (5). Thus, by assigning ξ
l(i)
i to ξ
l∗(i)
i it follows that
the ξ
l∗(i)
i remain feasible for problem (11). Given that the remaining decision
variables do not change, (βl, βl0, ζ
l
j , ξ
l∗(i)
i , ∀i = 1, . . . , N+l , ∀j = 1, . . . , N−)
forms a feasible solution of problem (11). This solution has a cost equal to Ol.
Re-optimizing can produce an optimal value that is no worse. It follows that in
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every iteration of ACC, Z is monotonically non-increasing. Monotonicity and
the fact that Z is bounded below by zero, suffices to establish convergence.
D Proof of Theorem 4.4
Proof: The proof is based on Lemma 2 of [55]. Given an assignment of each
positive sample i to cluster l(i), define L clustering functions
gl(i) =
{
1, if l(i) = l,
0, otherwise.
Hence, positive sample i is assigned to cluster arg maxl gl(i). This can be viewed
as the output of (L − 1)L/2 comparisons between pairs of gl1 and gl2 , where
1 ≤ l1 < l2 ≤ L. This pairwise comparison could be further transformed into
a boolean function (i.e., sgn(gl1 − gl2)). Together with the L classifiers (one
for each cluster), we have a total of (L + 1)L/2 boolean functions. Among all
these boolean functions, the maximum VC-dimension is D+ 1, because at most
D features are being used as input. Therefore, by Lemma 2 of [55], the VC-
dimension of the function familyH is bounded by 2( (L+1)L2 )(D+1) log(e (L+1)L2 ),
or equivalently (L+ 1)L(D + 1) log(e (L+1)L2 ).
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Table 1: Medical Factors in the Heart Diseases Dataset.
Ontology
Number
of Factors
Examples
Demographics 4 Sex, Age, Race, Zip Code
Diagnoses 22
e.g., Acute Myocardial Infarction (ICD9: 410), Cardiac
Dysrhythmias (ICD9: 427), Heart Failure (ICD9: 428),
Acute Pulmonary Heart Disease (ICD9: 415), Diabetes
Mellitus with Complications (ICD9: 250.1-250.4, 250.6-
250.9), Obesity (ICD9: 278.0)
Procedures
CPT
3
Cardiovascular Procedures (including CPT 93501, 93503,
93505, etc.), Surgical Procedures on the Arteries and Vein
(including CPT 35686, 35501, 35509, etc.), Surgical Proce-
dures on the Heart and Pericardium (including CPT 33533,
33534, 33535)
Procedures
ICD9
4
Operations on the Cardiovascular System (ICD9: 35-
39.99), Cardiac Stress Test and pacemaker checks (ICD9:
89.4), Angiocardiography and Aortography (ICD9: 88.5),
Diagnostic Ultrasound of Heart (ICD9: 88.72)
Vitals 2 Diastolic Blood Pressure, Systolic Blood Pressure
Lab Tests 4
CPK (Creatine phosphokinase) (LOINC:2157-6), CRP
Cardio (C-reactive protein) (LOINC:30522-7), Direct LDL
(Low-density lipoprotein) (LOINC:2574-2), HDL (High-
Density Lipoprotein) (LOINC:9830-1)
Tobacco 2 Current Cigarette Use, Ever Cigarette Use
Visits to
the ER
1 Visits to the Emergency Room
Admissions 17
e.g., Heart Transplant or Implant of Heart Assist System
(MSDRG: 001, 002), Cardiac Valve and Other Major Car-
diothoracic procedures (MSDRG: 216-221), Coronary By-
pass (MSDRG: 231-234), Acute Myocardial Infarction (MS-
DRG: 280-285), Heart Failure and Shock (MSDRG: 291-
293), Cardiac Arrest (MSDRG: 296-298), Chest Pain (MS-
DRG: 313), Respiratory System related admissions (MS-
DRG: 175-176, 190-192)
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Table 2: Medical Factors in the Diabetes Dataset.
Ontology Examples
Demographics Sex, Age, Race, Zip Code
Diagnoses e.g., Diabetes mellitus with complications, Thyroid
disorders, Hypertensive disease, Pulmonary heart
disease, Heart failure, Aneurysm, Skin infections,
Abnormal glucose tolerance test, Family history of
diabetes mellitus
Procedures
(CPT or
ICD9)
e.g., Procedure on single vessel, Insertion of intraoc-
ular lens prosthesis at time of cataract extraction,
Venous catheterization, Hemodialysis, Transfusion of
packed cells
Admissions e.g., Diabetes (with and without) complications,
Heart failure and shock, Deep Vein Throm-
bophlebitis, Renal failure, Chest pain, Chronic ob-
structive pulmonary disease, Nutritional. & misc
metabolic disorders, Bone Diseases & Arthropathies,
Kidney & urinary tract infections, Acute myocardial
infarction, O.R. procedures for obesity, Hypertension
Service by
Department
Inpatient (admit), Inpatient (observe), Outpatient,
Emergency Room
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Table 3: Quantization of Features.
Features Levels of
quantiza-
tion
Comments
Sex 3 0 represents missing information
Age 6 Thresholds at 40, 55, 65, 75 and 85 years old
Race 10
Zip Code 0 Removed due to its vast variation
Tobacco (Current
and Ever Cigarette
Use)
2 Indicators of tobacco use
Diastolic Blood
Pres-sure (DBP)
3 Level 1 if DBP< 60mmHg, Level 2 if 60mmHg
≤ DBP ≤ 90mmHg and Level 3 if DBP >
90mmHg
Systolic Blood Pres-
sure (SBP)
3 Level 1 if SBP < 90mmHg, Level 2 if 90mmHg
≤ SBP ≤ 140mmHg and Level 3 if SBP >
140mmHg
Lab Tests 2 Existing lab record or Non-Existing lab record
in the specific time period
All other dimensions 7 Thresholds are set to 0.01%, 5%, 10%, 20%,
40% and 70% of the maximum value of each
dimension
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Table 4: Prediction accuracy (AUC) on heart data.
Settings avg. AUC std AUC
ACC, L = 1 (SLSVM) 76.54% 0.59%
ACC, L = 2 76.83% 0.87%
ACC, L = 3 77.06% 1.04%
ACC, L = 4 75.14% 0.92%
ACC, L = 5 75.14% 1.00%
ACC, L = 6 74.32% 0.87%
4-LRT 75.78% 0.53%
Lin. SVM 72.83% 0.51%
RBF SVM 73.35% 1.07%
sparse LR 75.87% 0.67%
CT-LSVM (L = 2) 71.31% 0.76%
CT-SLSVM (L = 2) 71.97% 0.73%
random forests 81.62% 0.37%
FRF 10-yr risk 56.48% 1.09%
random forests on FRF features 62.20% 1.13%
Table 5: Prediction Accuracy (AUC) on diabetes data.
Settings avg. AUC std AUC
ACC, L = 1 (SLSVM) 79.24% 0.52%
ACC, L = 2 78.55% 0.41%
ACC, L = 3 78.53% 0.41%
ACC, L = 4 78.46% 0.35%
ACC, L = 5 78.36% 0.36%
ACC, L = 6 78.18% 0.50%
4-LRT 78.74% 0.28%
Lin. SVM 76.87% 0.48%
RBF SVM 77.96% 0.27%
sparse LR 78.91% 0.38%
CT-LSVM (L = 2) 75.63% 0.50%
CT-SLSVM (L = 2) 77.99% 0.49%
random forests 84.53% 0.26%
random forests on selected features (baseline) 65.77% 0.47%
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Table 6: Top 10 significant features for 1-LRT.
1-LRT 1-LRT
Importance Score Feature Name
10.50 Admission of heart failure, 1 year before the
target year
9.71 Age
6.23 Diagnosis of heart failure, 1 year before the
target year
5.43 Admission with other circulatory system diag-
noses, 1 year before the target year
4.38 Diagnosis of heart failure, 2 years before the
target year
4.16 Diagnosis of hematologic disease, 1 year before
the target year
3.45 Diagnosis of diabetes mellitus w/o complica-
tions, 1 year before the target year
3.40 Symptoms involving respiratory system and
other chest symp-toms, 1 year before the tar-
get year
3.24 visit to the Emergency Room, 1 year before
the target year
3.13 Lab test CPK, 1 year before the target year
40
